| Jul 1, 2026 (view filing)8:09 PM ET | Jun 29-Jul 1 | 2 days | Stephenson Brian CChief Financial Officer | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +13.6K | $23.92 | +$326.1K | +41.2%46.7K after | 6 lotsThis row combines 6 trades of the same kind from one filing. The price is the value-weighted average. |
| Jun 26, 2026 (view filing) | Jun 24-26 | 2 days | Stephenson Brian CChief Financial Officer | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +15.6K | $25.65 | +$401.3K | +89.8%33.1K after | 8 lotsThis row combines 8 trades of the same kind from one filing. The price is the value-weighted average. |
| Jun 24, 2026 (view filing) | Jun 22 | 2 days | Parikh Anand KiranPresident and CEO | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +2.81K | $19.76 | +$55.4K | +0.4%764.2K after | |
| Jun 24, 2026 (view filing) | Jun 22-23 | 2 days | Stephenson Brian CChief Financial Officer | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +17.4K | $23.31 | +$405.9K | New position17.4K after | 8 lotsThis row combines 8 trades of the same kind from one filing. The price is the value-weighted average. |
| Jun 1, 2026 (view filing) | Jun 1 | Same day | Cambrian BioPharma Inc10% Owner | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −25.0K | $20.02 | −$500.5K | −16.1%130.1K after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Jun 1, 2026 (view filing) | Jun 1 | Same day | Peyer James10% Owner, Other: See remarks below | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −25.0K | $20.02 | −$500.5K | −16.1%130.1K after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| May 15, 2026 (view filing)4:24 PM ET | Apr 2-7 | 43 daysLateFiled more than 2 business days after the trade (the Form 4 deadline). A few cases, such as trades a broker makes under a 10b5-1 plan, have a longer deadline, so this flag comes from the dates alone and does not mean a rule was broken. | Englander Israel A and 3 others10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +4.21K | $33.54 | +$141.4K | +3.2%134.0K after | 5 lotsThis row combines 5 trades of the same kind from one filing. The price is the value-weighted average. |
| May 15, 2026 (view filing)4:24 PM ET | Apr 2-7 | 43 daysLateFiled more than 2 business days after the trade (the Form 4 deadline). A few cases, such as trades a broker makes under a 10b5-1 plan, have a longer deadline, so this flag comes from the dates alone and does not mean a rule was broken. | Englander Israel A and 3 others10% Owner | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −17.1K | $31.51 | −$538.1K | −11.3%134.0K after | 12 lotsThis row combines 12 trades of the same kind from one filing. The price is the value-weighted average. |
| May 15, 2026 (view filing)4:22 PM ET | Mar 31-Apr 1 | 45 daysLateFiled more than 2 business days after the trade (the Form 4 deadline). A few cases, such as trades a broker makes under a 10b5-1 plan, have a longer deadline, so this flag comes from the dates alone and does not mean a rule was broken. | Englander Israel A and 3 others10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +12.2K | $31.37 | +$382.1K | +9.0%147.7K after | 10 lotsThis row combines 10 trades of the same kind from one filing. The price is the value-weighted average. |
| May 15, 2026 (view filing)4:22 PM ET | Mar 31-Apr 1 | 45 daysLateFiled more than 2 business days after the trade (the Form 4 deadline). A few cases, such as trades a broker makes under a 10b5-1 plan, have a longer deadline, so this flag comes from the dates alone and does not mean a rule was broken. | Englander Israel A and 3 others10% Owner | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −2.74K | $28.07 | −$76.9K | −1.8%147.7K after | 7 lotsThis row combines 7 trades of the same kind from one filing. The price is the value-weighted average. |
| May 15, 2026 (view filing)4:22 PM ET | Mar 26-30 | 50 daysLateFiled more than 2 business days after the trade (the Form 4 deadline). A few cases, such as trades a broker makes under a 10b5-1 plan, have a longer deadline, so this flag comes from the dates alone and does not mean a rule was broken. | Englander Israel A and 3 others10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +30.6K | $26.75 | +$818.3K | +26.6%145.7K after | 11 lotsThis row combines 11 trades of the same kind from one filing. The price is the value-weighted average. |
| May 15, 2026 (view filing)4:22 PM ET | Mar 26-30 | 50 daysLateFiled more than 2 business days after the trade (the Form 4 deadline). A few cases, such as trades a broker makes under a 10b5-1 plan, have a longer deadline, so this flag comes from the dates alone and does not mean a rule was broken. | Englander Israel A and 3 others10% Owner | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −3.25K | $27.50 | −$89.4K | −2.2%145.7K after | 6 lotsThis row combines 6 trades of the same kind from one filing. The price is the value-weighted average. |
| Dec 10, 2025 (view filing) | Dec 9 | 1 day | Cambrian BioPharma Inc10% Owner | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −6.61K | $8.25 | −$54.6K | −4.1%155.1K after | 4 lotsThis row combines 4 trades of the same kind from one filing. The price is the value-weighted average. |
| Dec 10, 2025 (view filing) | Dec 8-9 | 2 days | Peyer James10% Owner, Other: See remarks below | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −6.61K | $8.25 | −$54.6K | −4.1%155.1K after | 4 lotsThis row combines 4 trades of the same kind from one filing. The price is the value-weighted average. |
| Dec 8, 2025 (view filing) | Dec 4-5 | 4 days | Cambrian BioPharma Inc10% Owner | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −21.3K | $10.93 | −$232.7K | −11.7%161.4K after | 4 lotsThis row combines 4 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Dec 8, 2025 (view filing) | Dec 4-5 | 4 days | Peyer James10% Owner, Other: See remarks below | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −21.3K | $10.93 | −$232.7K | −11.7%161.4K after | 4 lotsThis row combines 4 trades of the same kind from one filing. The price is the value-weighted average. |
| Sep 13, 2023 (view filing) | Sep 11 | 2 days | Celebi JohnPresident and CEO | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +500 | $0.85 | +$425 | +0.5%111.3K after | |
| Jun 2, 2023 (view filing)5:03 PM ET | Jun 1 | 1 day | Presight Sensei Co-Invest Fund, L.P. and 3 othersOther: See Explanation of Responses | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −3.44M | $1.58 | −$5.44M | −100.0%0 after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Feb 27, 2023 (view filing)8:10 PM ET | Feb 23 | 4 days | Presight Sensei Co-Invest Fund, L.P. and 3 othersOther: See Explanation of Responses | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +2.20K | $1.61 | +$3.54K | +0.1%2.49M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Jun 10, 2022 (view filing) | Mar 2 | 100 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +1.20K | $3.20 | +$3.85K | 0.0%5.23M after | AmendedAn amended filing (for example Form 4/A or 13F-HR/A) that corrects or adds to an earlier filing.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Jun 10, 2022 (view filing) | Mar 2 | 100 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +1.20K | $3.20 | +$3.85K | 0.0%5.23M after | AmendedAn amended filing (for example Form 4/A or 13F-HR/A) that corrects or adds to an earlier filing. |
| Apr 21, 2022 (view filing) | Mar 23, 2021 | 394 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +9.50K | $14.34 | +$136.2K | +0.2%4.80M after | AmendedAn amended filing (for example Form 4/A or 13F-HR/A) that corrects or adds to an earlier filing.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Apr 21, 2022 (view filing) | Feb 18, 2021 | 427 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +752 | $19.75 | +$14.9K | 0.0%4.69M after | AmendedAn amended filing (for example Form 4/A or 13F-HR/A) that corrects or adds to an earlier filing.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Apr 21, 2022 (view filing) | Mar 23, 2021 | 394 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +9.50K | $14.34 | +$136.2K | +0.2%4.80M after | AmendedAn amended filing (for example Form 4/A or 13F-HR/A) that corrects or adds to an earlier filing. |
| Apr 21, 2022 (view filing) | Feb 18, 2021 | 427 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +752 | $19.75 | +$14.9K | 0.0%4.69M after | AmendedAn amended filing (for example Form 4/A or 13F-HR/A) that corrects or adds to an earlier filing. |
| Mar 1, 2022 (view filing) | Feb 28-Mar 1 | 1 day | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +2.50K | $3.60 | +$9.00K | 0.0%5.23M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Mar 1, 2022 (view filing) | Feb 28-Mar 1 | 1 day | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +2.50K | $3.60 | +$9.00K | 0.0%5.23M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Feb 28, 2022 (view filing) | Feb 25 | 3 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +2.50K | $3.65 | +$9.13K | 0.0%5.23M after | Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Feb 28, 2022 (view filing) | Feb 25 | 3 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +2.50K | $3.65 | +$9.13K | 0.0%5.23M after | |
| Feb 24, 2022 (view filing) | Feb 23-24 | 1 day | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +17.5K | $3.65 | +$64.0K | +0.3%5.23M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Feb 24, 2022 (view filing) | Feb 23-24 | 1 day | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +17.5K | $3.65 | +$64.0K | +0.3%5.23M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Feb 22, 2022 (view filing) | Feb 17-18 | 5 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +19.9K | $4.02 | +$80.2K | +0.4%5.21M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Feb 22, 2022 (view filing) | Feb 17-18 | 5 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +19.9K | $4.02 | +$80.2K | +0.4%5.21M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Feb 16, 2022 (view filing) | Feb 14-16 | 2 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +12.6K | $4.19 | +$52.6K | +0.2%5.19M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Feb 16, 2022 (view filing) | Feb 14 | 2 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +10.0K | $4.18 | +$41.8K | +0.2%5.19M after | |
| Feb 16, 2022 (view filing) | Feb 16 | Same day | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +2.55K | $4.25 | +$10.8K | 0.0%5.19M after | |
| Feb 14, 2022 (view filing) | Feb 10-11 | 4 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +17.5K | $4.45 | +$77.9K | +0.3%5.18M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Feb 14, 2022 (view filing) | Feb 10-11 | 4 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +17.5K | $4.45 | +$77.9K | +0.3%5.18M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Feb 8, 2022 (view filing) | Feb 3-8 | 5 daysLateFiled more than 2 business days after the trade (the Form 4 deadline). A few cases, such as trades a broker makes under a 10b5-1 plan, have a longer deadline, so this flag comes from the dates alone and does not mean a rule was broken. | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +30.0K | $4.53 | +$135.8K | +0.6%5.16M after | 3 lotsThis row combines 3 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Feb 8, 2022 (view filing) | Feb 3-8 | 5 daysLateFiled more than 2 business days after the trade (the Form 4 deadline). A few cases, such as trades a broker makes under a 10b5-1 plan, have a longer deadline, so this flag comes from the dates alone and does not mean a rule was broken. | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +30.0K | $4.53 | +$135.8K | +0.6%5.16M after | 3 lotsThis row combines 3 trades of the same kind from one filing. The price is the value-weighted average. |
| Jan 31, 2022 (view filing) | Jan 27-28 | 4 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +15.0K | $4.26 | +$63.8K | +0.3%5.13M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Jan 31, 2022 (view filing) | Jan 27-28 | 4 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +15.0K | $4.26 | +$63.8K | +0.3%5.13M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Jan 27, 2022 (view filing) | Jan 25-26 | 2 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +50.0K | $4.72 | +$235.8K | +1.0%5.11M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Jan 27, 2022 (view filing) | Jan 25-26 | 2 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +50.0K | $4.72 | +$235.8K | +1.0%5.11M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Jan 25, 2022 (view filing) | Jan 21-24 | 4 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +47.4K | $4.82 | +$228.5K | +0.9%5.06M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Jan 25, 2022 (view filing) | Jan 21-24 | 4 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +47.4K | $4.82 | +$228.5K | +0.9%5.06M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Jan 21, 2022 (view filing) | Jan 19-20 | 2 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +30.2K | $5.10 | +$154.3K | +0.6%5.02M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Jan 21, 2022 (view filing) | Jan 19-20 | 2 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +30.2K | $5.10 | +$154.3K | +0.6%5.02M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Jan 20, 2022 (view filing) | Jan 18 | 2 days | Peyer JamesDirector, 10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +10.0K | $5.08 | +$50.8K | +0.2%4.99M after | Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Jan 20, 2022 (view filing) | Jan 18 | 2 days | Cambrian BioPharma Inc10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +10.0K | $5.08 | +$50.8K | +0.2%4.99M after | |
